For people diagnosed with macular telangiectasia type 2 (MacTel)-a rare and slowly progressing retinal disease-there have ...

Innovations in immunotherapies and personalized medicine, along with increased healthcare investments, are reshaping cancer ...

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs – used ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

A French pharmaceutical giant is acquiring a biotech and its rare immunology disease treatment which is already approved in ...

Tolerance Bio is targeting an often-overlooked organ — the thymus — with cell therapy to help kids with DiGeorge syndrome, and potentially extend lifespan in adults.

There's no reason the U.S. can't pick up the pace to match the global clinical research front-runners without compromising ...

Bristol Myers Squibb leapt into the drug industry’s most intense new rivalry on Monday, signing a deal to potentially spend ...

An outbreak of Salmonella infections traced to cucumbers from Florida is growing. As of May 30, 45 people across 18 states had been infected. Sixteen ...